CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Biorestorative Therapies, Inc.  (BRTX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Biorestorative Therapies's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

BRTX Gross Margin (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Revenue Change 23.8 % -23.29 % -96.95 % -94.8 % -89.14 %
Y / Y Gross Profit Change - - -95.66 % - -78.3 %
Gross Margin - - 99.65 % - 99.56 %
Gross Margin Total Ranking # 518 # 473 # 0 # 0 # 0
Seq. Revenue Change 185.71 % 15.23 % 21.5 % -69.05 % 77.04 %
Seq. Gross Profit Change - - 21.08 % - 76.46 %


Commenting Second Quarter 2017 Gross Margin
Biorestorative Therapies has managed to improve its Revenue sequentially to $0 millions by 185.71 % faster than Gross Profit increase of 185.71 % to $0 millions, this led to contraction in Gross Margin to 100 %, but the Biorestorative Therapies II. Quarter Gross Margin remained above company average rate of 83.28%.

Observing second quarter 2017 results within Biotechnology & Drugs industry 44 other companies have achieved higher Gross Margin. While overall Gross Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Gross Margin
BRTX's Gross Margin second quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 45
Healthcare Sector # 137
Overall # 518

Gross Margin Statistics
High Average Low
100 % 83.28 % 47.02 %
(Jun 30 2017)   (Sep 30 2015)

You need to upgrade your Flash Player


Financial Statements
Biorestorative Therapies's (Jun 30 2017) Gross Profit $ 0 BRTX's Income Statement
Biorestorative Therapies's (Jun 30 2016) Gross Profit $ 0 Quarterly BRTX's Growth
BRTX's Profits by Division See BRTX's Profits by Segment

Other Gross Margin Profitability Ratios
BRTX's Cumulative Gross Margin
Biotechnology & Drugs Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
BRTX's Gross Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for BRTX's Competitors
Gross Margin Profit Margin for Biorestorative Therapies's Suppliers
Gross Margin Profit Margin for BRTX's Customers

You may also want to know
BRTX's Annual Growth Rates BRTX's Profitability Ratios BRTX's Asset Turnover Ratio BRTX's Dividend Growth
BRTX's Roe BRTX's Valuation Ratios BRTX's Financial Strength Ratios BRTX's Gross Profit Growth
BRTX's Roa BRTX's Inventory Turnover Ratio BRTX's Growth Rates BRTX's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Jun 30 2017, within Biotechnology & Drugs Industry Gross MarginJun 30 2017 MRQ Gross ProfitJun 30 2017 MRQ Revenue
Dimension Therapeutics, Inc.  100.00 %$ 4.369 $ 4.369 
Neuralstem, Inc.  100.00 %$ 0.003 $ 0.003 
Repros Therapeutics Inc.  100.00 %$ 0.007 $ 0.007 
Spark Therapeutics, Inc.  100.00 %$ 1.483 $ 1.483 
Enzon Pharmaceuticals, Inc.  100.00 %$ 6.775 $ 6.775 
Enumeral Biomedical Holdings, Inc.  100.00 %$ 0.379 $ 0.379 
Cytomx Therapeutics, Inc.  100.00 %$ 8.752 $ 8.752 
Champions Oncology, Inc.  100.00 %$ 5.033 $ 5.033 
Cerecor Inc.  100.00 %$ 0.158 $ 0.158 
Syndax Pharmaceuticals Inc  100.00 %$ 0.305 $ 0.305 
Coherus Biosciences, Inc.  100.00 %$ 1.395 $ 1.395 
Novavax Inc  100.00 %$ 6.732 $ 6.732 
Crispr Therapeutics Ag  100.00 %$ 3.582 $ 3.582 
Curis Inc  100.00 %$ 2.061 $ 2.061 
Fate Therapeutics Inc  100.00 %$ 1.026 $ 1.026 
Foamix Pharmaceuticals Ltd.  100.00 %$ 0.798 $ 0.798 
Myokardia Inc  100.00 %$ 5.625 $ 5.625 
Mymetics Corp  100.00 %$ 0.317 $ 0.317 
Northsight Capital, Inc.  100.00 %$ 0.006 $ 0.006 
Nantkwest, Inc.  100.00 %$ 0.014 $ 0.014 
Intellia Therapeutics, Inc.  100.00 %$ 5.917 $ 5.917 
Regen Biopharma Inc  100.00 %$ 0.110 $ 0.110 
Momenta Pharmaceuticals Inc  100.00 %$ 23.570 $ 23.570 
Proteostasis Therapeutics, Inc.  100.00 %$ 1.147 $ 1.147 
Idera Pharmaceuticals, Inc.  100.00 %$ 0.187 $ 0.187 
Regenerx Biopharmaceuticals Inc  100.00 %$ 0.013 $ 0.013 
Innovus Pharmaceuticals, Inc.  100.00 %$ 2.039 $ 2.039 
Juno Therapeutics, Inc.  100.00 %$ 21.268 $ 21.268 
Kite Pharma, Inc.  100.00 %$ 10.052 $ 10.052 
Tracon Pharmaceuticals, Inc.  100.00 %$ 0.631 $ 0.631 
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMED's Profile

Stock Price

SMED's Financials

SMED's Expectations

Business Description

Fundamentals

Charts & Quotes

SMED's News

Suppliers

SMED's Competitors

Customers & Markets

Economic Indicators

SMED's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com